Get more Mail & Guardian
Subscribe or Login

Kenya anti-Aids drive gets $132m boost

The Global Fund to Fight Aids, Tuberculosis and Malaria has approved a grant of $132,3-million to boost Kenya’s anti-HIV/Aids drive, the Health Ministry announced on Tuesday.

The grant will finance programmes over the next five years, but an initial amount of $47,1-million will be released in the first two years, said Health Ministry permanent secretary Hezron Nyangito.

”The new grant to Kenya is targeted to provide ARV [antiretroviral] treatment with inclusion of a nutrition component, strengthening of health systems and strategic communication,” he said.

The grant brings the total funding for HIV/Aids, malaria and tuberculosis programmes in Kenya to $306-million since the fund was created in 2002.

Kenya’s official Aids prevalence rate is 5,1%, down from 5,9% in 2005 due to the use of free ARV therapy for adults and distributing new drugs to prevent mother-to-child transmission.

Since the savage virus roared from African jungles in the early 1980s, sub-Saharan Africa accounts for a staggering 72% of global Aids deaths, and two-thirds of all people infected with HIV.

After the disease was first diagnosed in Kenya in 1984, it has killed at least 1,5-million people and overturned decades of healthcare gains, and now threatens to burn through development efforts if it is not reversed.

By June last year, about one million Africans were receiving anti-retroviral drugs. This was still less than one-quarter of the estimated 4,6-million people in need of the drugs on the continent. — Sapa-AFP

Subscribe for R500/year

Thanks for enjoying the Mail & Guardian, we’re proud of our 36 year history, throughout which we have delivered to readers the most important, unbiased stories in South Africa. Good journalism costs, though, and right from our very first edition we’ve relied on reader subscriptions to protect our independence.

Digital subscribers get access to all of our award-winning journalism, including premium features, as well as exclusive events, newsletters, webinars and the cryptic crossword. Click here to find out how to join them and get a 57% discount in your first year.

Related stories

WELCOME TO YOUR M&G

If you’re reading this, you clearly have great taste

If you haven’t already, you can subscribe to the Mail & Guardian for less than the cost of a cup of coffee a week, and get more great reads.

Already a subscriber? Sign in here

Advertising

Subscribers only

South Africa’s mothballed ‘supermall-ification’ sets strip malls up for success

Analysts agree that the country has enough malls and that, post-Covid, the convenience of local centres lure customers

Mabuza’s Russian jaunts and the slippery consequences of medical tourism

For more than five years the deputy president has remained steadfast in his right to travel abroad to receive medical treatment

More top stories

Deputy president Mabuza begs Tshwane voters: ‘Don’t abandon the ANC’

Angry Atteridgeville residents hurl insults at ‘dysfunctional’ ANC full of ‘corrupt individuals’ as Mabuza fails to placate them with party T-shirts and doeks

Taxi operators clash with cops over disputed Route B97 in...

Three suspects remain in custody following their arrest on charges of attempted murder and assault after eight taxis were impounded

SA teens, you’re next in the queue for a vaccine...

Teenagers between the ages of 12 and 17 will be able to register to receive their Covid-19 jab from 20 October. This group will be given only one dose of the Pfizer vaccine, for now

Former US secretary of state Colin Powell dies aged 84

The 84-year-old died as a result of complications from Covid-19
Advertising

press releases

Loading latest Press Releases…
×